dorsaVi Ltd (ASX:DVL)
Australia · Delayed Price · Currency is AUD 0.0270
0.00 (0.00%)
Sep 25, 2026, 4:10 PM AEST
dorsaVi Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 1 | 1 | 1.13 | 1.3 | 1.75 | 2.35 |
Revenue Growth | 0.45% | -11.13% | -13.40% | -25.49% | -25.62% | 25.91% |
Gross Profit Gross Profit Growth | 0.71 | 0.71 | 0.97 | 1.18 | 1.5 | 2.08 |
Operating Income Operating Income Growth | -7.02 | -7.02 | -1.52 | -1.69 | -2.3 | -2.68 |
Net Income Net Income Growth | -8.52 | -8.52 | -1.52 | -1.25 | -1.82 | -1.54 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Workplace Workplace Growth | 0.18 | 0.18 | 0.28 | 0.34 | 0.7 | 0.73 |
Clinical Clinical Growth | 0.83 | 0.83 | 0.84 | 0.96 | 1.05 | 1.63 |
Total Total Growth | 1 | 1 | 1.13 | 1.3 | 1.75 | 2.35 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 2.12 | 2.12 | 2.29 | 0.48 | 0.88 | 0.45 |
Total Debt Total Debt Growth | 0.07 | 0.07 | 0.16 | 0.19 | 0.32 | 1.18 |
Net Cash (Debt) Net Cash Growth | 2.06 | 2.06 | 2.14 | 0.29 | 0.56 | -0.73 |
Net Cash Growth | -57.71% | -3.78% | 642.08% | -48.30% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -5.28 | -5.28 | -0.89 | -0.6 | -0.97 | -2.15 |
Capital Expenditures CapEx Growth | - | - | - | -0 | -0.01 | -0.06 |
Free Cash Flow Free Cash Flow Growth | -5.28 | -5.28 | -0.89 | -0.6 | -0.98 | -2.22 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 70.83% | 70.83% | 86.04% | 90.53% | 85.68% | 88.19% |
Operating Margin | -699.11% | -699.11% | -134.97% | -129.77% | -131.27% | -114.03% |
Pretax Margin | -849.21% | -849.21% | -134.37% | -130.66% | -131.79% | -89.17% |
Profit Margin | -849.21% | -849.21% | -134.38% | -95.66% | -104.01% | -65.28% |
FCF Margin | -525.59% | -525.59% | -78.54% | -46.32% | -56.13% | -94.29% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Forward PE | - | 21.14 | 21.14 | 21.14 | 21.14 | 21.14 |
PS Ratio | 33.22 | 43.06 | 11.17 | 5.19 | 3.48 | 1.82 |